Health Care Industry
Industry: Email Alert RSS FeedTaro's Clobetasol emollient wins approval of its ANDA
Drug Store News, June 26, 2000
Taro Pharmaceutical Industries reported that Taro Pharmaceuticals U.S.A., the company's U.S. subsidiary, has received Food and Drug Administration approval of its ANDA for Clobetasol Propionate emollient cream USP, 0.05% ("Clobetasol E Cream"). The product is a high potency topical corticosteroid indicated for the treatment of moderate to severe dermatologic conditions and bioequivalent to Glaxo Welcome's Temovate emollient cream. The company said it now provides the full line of generic Clobetasol products, including Clobetasol Propionate cream, ointment, gel and topical solution.
Most RecentHealth Care Articles
Clobetasol "e cream" is the sixth approval this quarter for Taro.
COPYRIGHT 2000 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with
